Evaluation of platelet function under high shear condition in the small-sized collagen bead column

Journal of Laboratory and Clinical Medicine

Volumn 146, Issue 2, 2005, Pages 64-75

  Kaneko, Makoto ^b   Takafuta, Toshiro ^b   Cuyun Lira, Olga ^b   Satoh, Kaneo ^b   Arai, Morio ^b   Yatomi, Yutaka ^b   Ozaki, Yukio ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

15 CYCLOPENTYL 14 OXO 13 AZA 16,17,18,19,20 PENTANORPINANE THROMBOXANE A2; ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE 3',5' DIPHOSPHATE; ADENOSINE DIPHOSPHATE; AR C 69931MX; COLLAGEN TYPE 1; CREATINE KINASE; CREATINE PHOSPHATE; GLYCOPROTEIN IB; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AJVW 2 2; MONOCLONAL ANTIBODY RU5; PURINERGIC RECEPTOR BLOCKING AGENT; THROMBOXANE A2; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; CONTROLLED STUDY; EXPECTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MATERIAL COATING; MEDICAL ASSESSMENT; PARTICLE SIZE; PATIENT MONITORING; PROTEIN PROTEIN INTERACTION; SHEAR STRESS; SWINE; THROMBOCYTE ACTIVATION; THROMBOSIS;

ANTIBODIES; BLOOD COAGULATION; BLOOD PLATELETS; CHROMATOGRAPHY; COLLAGEN; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RHEOLOGY; RISTOCETIN; SHEAR STRENGTH; VON WILLEBRAND FACTOR;

EID: 23744436963     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.04.007     Document Type: Article

References (48)

1. B. Wiman, T. Andersson, J. Hallqvist, C. Reuterwall, A. Ahlbom, U. deFaire Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) Study Arterioscler Thromb Vasc Biol 20 2000 2019 2023
2. K. Eto, T. Isshiki, H. Yamamoto AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes Arterioscler Thromb Vasc Biol 19 1999 877 882
3. A.R. Folsom, K.K. Wu, W.D. Rosamond, A.R. Sharrett, L.E. Chambless Prospective study of hemostatic factors and incidence of coronary heart disease The Atherosclerosis Risk in Communities (ARIC) Study Circulation 96 1997 1102 1108
4. S. Goto, H. Sakai, M. Goto Enhanced shear-induced platelet aggregation in acute myocardial infarction Circulation 99 1999 608 613
5. J. Jansson, T. Nilsson, O. Johnson von Willebrand factor in plasma a novel risk factor for recurrent myocardial infarction and death Br Heart J 66 1991 351 355
6. N. Qizilbash, S. Duffy, C. Prentice, M. Boothby, C. Warlow Von Willebrand factor and risk of ischemic stroke Neurology 49 1997 1552 1556
7. S. Uchiyama, M. Yamazaki, S. Maruyama Shear-induced platelet aggregation in cerebral ischemia Stroke 25 1994 1547 1551
8. A.R. Folsom, W.D. Rosamond, E. Shahar Prospective study of markers of hemostatic function with risk of ischemic stroke Circulation 100 1999 736 742
9. J.L. Moake von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura Semin Hematol 41 2004 4 14
10. J.E. Sadler A new name in thrombosis, ADAMTS13 Proc Natl Acad Sci U S A 99 2002 11552 11554
11. G.V.R. Born Aggregation of blood platelets by adenosine diphosphate and its reversal Nature 194 1962 927 929
12. M.E. Carr Jr In vitro assessment of platelet function Transfus Med Rev 11 1997 106 115
13. Y. Ikeda, M. Handa, K. Kawano The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress J Clin Invest 87 1991 1234 1240
14. P. Harrison Progress in the assessment of platelet function Br J Haematol 111 2000 733 744
15. E.J. Favaloro Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder Best Pract Res Clin Haematol 14 2001 299 319
16. B. Jilma Platelet function analyzer (PFA-100) a tool to quantify congenital or acquired platelet dysfunction J Lab Clin Med 138 2001 152 163
17. J.L. Moake, N.A. Turner, N.A. Stathopoulos, L.H. Nolasco, J.D. Hellums Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation J Clin Invest 78 1986 1456 1461
18. B.S. Coller Monitoring platelet GP IIb/IIIa antagonist therapy Circulation 97 1998 5 9
19. E.W. Salzman Measurement of platelet adhesiveness. A simple in vitro technique demonstrating an abnormality in von Willebrand's disease J Lab Clin Med 62 1963 724 735
20. A.J. Hellem Platelet adhesiveness in von Willebrand's disease. A study with a new modification of the glass bead filter method Scand J Haematol 7 1970 374 382
21. E.C. Rossi, D. Green A study of platelet retention by glass bead columns ('platelet adhesiveness' in normal subjects) Br J Haematol 23 1972 47 57
22. M. Kaneko, O. Cuyun-Lira, T. Takafuta Mechanisms of platelet retention in the collagen-coated-bead column J Lab Clin Med 142 2003 258 267
23. R.A. Romijn, B. Bouma, W. Wuyster Identification of the collagen-binding site of the von Willebrand factor A3-domain J Biol Chem 276 2001 9985 9991
24. H.J. Weiss, L.W. Hoyer, F.R. Rickles, A. Varma, J. Rogers Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content J Clin Invest 52 1973 2708 2716
25. T. Ohmori, Y. Yatomi, N. Asazuma, K. Satoh, Y. Ozaki Involvement of proline-rich tyrosine kinase 2 in platelet activation tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2 Biochem J 347 2000 561 569
26. Z.M. Ruggeri, T.S. Zimmerman Variant von Willebrand's disease characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets J Clin Invest 65 1980 1318 1325
27. J.A. van Mourik, I.A. Mochtar Purification of human antihemophilic factor (factor VIII) by gel chromatography Biochim Biophys Acta 221 1970 677 679
28. Z.M. Ruggeri Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation Best Pract Res Clin Haematol 14 2001 257 279
29. J.L. Moake, N.A. Turner, N.A. Stathopoulos, L. Nolasco, J.D. Hellums Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin Blood 71 1988 1366 1374
30. K. Kondo, R. Seo, M. Naka Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis Eur J Pharmacol 163 1989 253 261
31. C. Gachet ADP receptors of platelets and their inhibition Thromb Haemost 86 2001 222 232
32. D.A. Gastineau, S.B. Moore How important are ABO-related variations in coagulation factor levels? Transfusion 41 2001 4 5
33. J. Sixma, K. Sakariassen, N. Beeser-Visser, M. Ottenhof-Rovers, P. Bolhuis Adhesion of platelets to human artery subendothelium effect of factor VIII-von Willebrand factor of various multimeric composition Blood 63 1984 128 139
34. L. Sporn, V. Marder, D. Wagner von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively Blood 69 1987 1531 1534
35. J.L. Spivak, G. Barosi, G. Tognoni Chronic myeloproliferative disorders Hematology 2003 2003 200 224
36. H.C. Kwaan, J. Wang Hyperviscosity in polycythemia vera and other red cell abnormalities Semin Thromb Hemost 29 2003 451 458
37. R. Knofler, G. Weissbach, E. Kuhlisch Release of adenosine triphosphate by adenosine diphosphate in whole blood and in erythrocyte suspensions Am J Hematol 56 1997 259 265
38. J.D. Emery, D.W. Leifer, G.L. Moura, P. Southern, J.H. Morrissey, J.B. Lawrence Whole-blood platelet aggregation predicts in vitro and in vivo primary hemostatic function in the elderly Arterioscler Thromb Vasc Biol 15 1995 748 753
39. T. Matsui, T. Shimoyama, M. Matsumoto ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation Blood 94 1999 2895 2900
40. J. Gill, J. Endres-Brooks, P. Bauer, W.J. Marks, R. Montgomery The effect of ABO blood group on the diagnosis of von Willebrand disease Blood 69 1987 1691 1695
41. Z.M. Ruggeri Von Willebrand factor, platelets and endothelial cell interactions J Thromb Haemost 1 2003 1335 1342
42. S.P. Jackson, W.S. Nesbitt, S. Kulkarni Signaling events underlying thrombus formation J Thromb Haemost 1 2003 1602 1612
43. K. Satoh, N. Asazuma, Y. Yatomi Activation of protein-tyrosine kinase pathways in human platelets stimulated with the A1 domain of von Willebrand factor Platelets 11 2000 171 176
44. B. Savage, E. Saldivar, Z.M. Ruggeri Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor Cell 84 1996 289 297
45. M.M. Frojmovic Platelet aggregation in flow differential roles for adhesive receptors and ligands Am Heart J 135 1998 S119 S131
46. K.E. Sarji, R.D. Stratton, R.H. Wagner, K.M. Brinkhous Nature of von Willebrand factor a new assay and a specific inhibitor Proc Natl Acad Sci U S A 71 1974 2937 2941
47. A.B. Federici Clinical diagnosis of von Willebrand disease Haemophilia 10 2004 169 176
48. E.J. Favaloro, D. Lillicrap, M.A. Lazzari von Willebrand disease laboratory aspects of diagnosis and treatment Haemophilia 10 2004 164 168